NASDAQ Health Care Index (IXHC) Companies by Market Cap
The NASDAQ Health Care Index (IXHC) tracks 976 constituent companies with a combined market cap of $2.51 Trillion, covering the largest publicly traded companies in USA. This ranking lists all IXHC index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$2.51 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 51 |
Nuvalent Inc
NASDAQ:NUVL |
% | $9.12 Billion | Healthcare | Biotechnology | $123.94 | +0.03% |
| 52 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
% | $9.08 Billion | Healthcare | Biotechnology | $110.40 | -7.50% |
| 53 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
% | $8.70 Billion | Healthcare | Biotechnology | $76.11 | -0.12% |
| 54 |
The Ensign Group Inc
NASDAQ:ENSG |
% | $8.60 Billion | Healthcare | Medical Care Facilities | $168.39 | -0.12% |
| 55 |
TG Therapeutics Inc
NASDAQ:TGTX |
% | $8.42 Billion | Healthcare | Biotechnology | $55.01 | -3.69% |
| 56 |
Blueprint Medicines Corp
NASDAQ:BPMC |
% | $8.36 Billion | Healthcare | Biotechnology | $129.46 | +0.14% |
| 57 |
Henry Schein Inc
NASDAQ:HSIC |
% | $7.86 Billion | Healthcare | Medical Distribution | $85.79 | +1.65% |
| 58 |
Repligen Corporation
NASDAQ:RGEN |
% | $7.68 Billion | Healthcare | Medical Instruments & Supplies | $144.88 | +0.44% |
| 59 |
Vaxcyte Inc
NASDAQ:PCVX |
% | $7.65 Billion | Healthcare | Biotechnology | $57.03 | -2.03% |
| 60 |
Alkermes Plc
NASDAQ:ALKS |
% | $7.49 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $51.87 | -0.13% |
| 61 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
% | $7.31 Billion | Healthcare | Biotechnology | $86.00 | +0.00% |
| 62 |
HealthEquity Inc
NASDAQ:HQY |
% | $7.17 Billion | Healthcare | Health Information Services | $95.66 | +1.33% |
| 63 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
% | $7.08 Billion | Healthcare | Biotechnology | $314.56 | -3.21% |
| 64 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
% | $6.96 Billion | Healthcare | Biotechnology | $221.38 | +0.03% |
| 65 |
Merus BV
NASDAQ:MRUS |
% | $6.83 Billion | Healthcare | Biotechnology | $90.00 | -7.14% |
| 66 |
Arcellx Inc
NASDAQ:ACLX |
% | $6.73 Billion | Healthcare | Biotechnology | $115.07 | +0.00% |
| 67 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
% | $6.64 Billion | Healthcare | Biotechnology | $93.73 | -4.10% |
| 68 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
% | $6.53 Billion | Healthcare | Biotechnology | $119.04 | -2.53% |
| 69 |
Liquidia Technologies Inc
NASDAQ:LQDA |
% | $6.33 Billion | Healthcare | Biotechnology | $71.21 | -8.62% |
| 70 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
% | $6.24 Billion | Healthcare | Biotechnology | $133.82 | +0.13% |
| 71 |
Belite Bio Inc ADR
NASDAQ:BLTE |
% | $6.17 Billion | Healthcare | Biotechnology | $164.45 | -1.77% |
| 72 |
PTC Therapeutics Inc
NASDAQ:PTCT |
% | $6.11 Billion | Healthcare | Biotechnology | $81.33 | -4.15% |
| 73 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
% | $6.10 Billion | Healthcare | Biotechnology | $39.43 | -0.10% |
| 74 |
Immunitybio Inc
NASDAQ:IBRX |
% | $5.96 Billion | Healthcare | Biotechnology | $7.79 | -5.23% |
| 75 |
Immunovant Inc
NASDAQ:IMVT |
% | $5.91 Billion | Healthcare | Biotechnology | $38.70 | -2.54% |
| 76 |
Cogent Biosciences Inc
NASDAQ:COGT |
% | $5.86 Billion | Healthcare | Biotechnology | $37.46 | -3.63% |
| 77 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
% | $5.84 Billion | Healthcare | Biotechnology | $107.49 | -0.84% |
| 78 |
Bruker Corporation
NASDAQ:BRKR |
% | $5.82 Billion | Healthcare | Medical Devices | $58.97 | -1.81% |
| 79 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
% | $5.79 Billion | Healthcare | Biotechnology | $72.50 | -3.64% |
| 80 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
% | $5.61 Billion | Healthcare | Biotechnology | $85.90 | -6.51% |
| 81 |
Erasca Inc
NASDAQ:ERAS |
% | $5.57 Billion | Healthcare | Biotechnology | $17.90 | -3.40% |
| 82 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
% | $5.36 Billion | Healthcare | Biotechnology | $98.64 | +1.07% |
| 83 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
% | $5.09 Billion | Healthcare | Biotechnology | $129.89 | -1.16% |
| 84 |
Lantheus Holdings Inc
NASDAQ:LNTH |
% | $4.93 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $105.39 | -0.24% |
| 85 |
Crispr Therapeutics AG
NASDAQ:CRSP |
% | $4.88 Billion | Healthcare | Biotechnology | $50.63 | -5.10% |
| 86 |
Celcuity LLC
NASDAQ:CELC |
% | $4.80 Billion | Healthcare | Biotechnology | $103.79 | -3.52% |
| 87 |
Legend Biotech Corp
NASDAQ:LEGN |
% | $4.78 Billion | Healthcare | Biotechnology | $25.75 | -4.91% |
| 88 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
% | $4.69 Billion | Healthcare | Biotechnology | $54.70 | -3.54% |
| 89 |
Sotera Health Co
NASDAQ:SHC |
% | $4.64 Billion | Healthcare | Diagnostics & Research | $18.17 | -1.36% |
| 90 |
RadNet Inc
NASDAQ:RDNT |
% | $4.58 Billion | Healthcare | Diagnostics & Research | $63.31 | -3.49% |
| 91 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
% | $4.55 Billion | Healthcare | Biotechnology | $14.49 | +0.00% |
| 92 |
Akero Therapeutics Inc
NASDAQ:AKRO |
% | $4.50 Billion | Healthcare | Biotechnology | $54.65 | +0.00% |
| 93 |
Waystar Holding Corp. Common Stock
NASDAQ:WAY |
% | $4.42 Billion | Healthcare | Health Information Services | $23.03 | +2.67% |
| 94 |
Twist Bioscience Corp
NASDAQ:TWST |
% | $4.31 Billion | Healthcare | Diagnostics & Research | $90.35 | -0.32% |
| 95 |
Merit Medical Systems Inc
NASDAQ:MMSI |
% | $4.24 Billion | Healthcare | Medical Instruments & Supplies | $73.26 | -0.25% |
| 96 |
Alignment Healthcare LLC
NASDAQ:ALHC |
% | $4.21 Billion | Healthcare | Healthcare Plans | $20.38 | +2.77% |
| 97 |
Lifestance Health Group Inc
NASDAQ:LFST |
% | $4.15 Billion | Healthcare | Medical Care Facilities | $10.88 | +1.63% |
| 98 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
% | $4.12 Billion | Healthcare | Biotechnology | $70.50 | +0.00% |
| 99 |
Travere Therapeutics Inc
NASDAQ:TVTX |
% | $3.96 Billion | Healthcare | Biotechnology | $56.29 | -0.53% |
| 100 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
% | $3.95 Billion | Healthcare | Biotechnology | $83.67 | +0.11% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices